Figure 3.
ORs (fremanezumab vs placebo) for achieving ≥50% reduction in monthly migraine days.
(a) Over 12 weeks of treatment (b) At 4 weeks of treatment.
OR, odds ratio; CI, confidence interval.
aClasses of migraine preventive medications.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.